Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun Any of a group of antibiotics originally isolated from a strain of the soil microorganism Streptomyces mediterranei, used in the United States to treat tuberculosis and prevent meningococcal infections, and used in other countries to treat leprosy and other bacterial diseases.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun Any of a group of
antibiotics , a subclass of theansamycins , which aresynthesized either naturally by thebacterium Amycolatopsis mediterranei orartificially .
Etymologies
from The American Heritage® Dictionary of the English Language, 4th Edition
Support
Help support Wordnik (and make this page ad-free) by adopting the word rifamycin.
Examples
-
In the long term, we like the position of the company, especially if Santarus can hold on to Zegerid until either budesonide or rifamycin − or both − gets on the market.
SeekingAlpha.com: Home Page Zacks.com 2010
-
In the long term, we like the position of the company, especially if Santarus can hold on to Zegerid until either budesonide or rifamycin − or both − gets on the market.
Healthcare Sector and Stocks Analysis from Seeking Alpha Zacks.com 2010
-
Santarus is also developing two late-stage lower GI product candidates, budesonide MMX® and rifamycin SV MMX®, for the U.S. market.
-
Meanwhile, pipeline candidates budesonide MMX and rifamycin SV MMX, if successfully developed, are not likely to hit the market before 2012.
-
Santarus expects to begin Phase III clinical testing of rifamycin SV MMX in patients with travelers 'diarrhea in the second quarter of 2010.
-
At best, rifamycin SV MMX is still years from the market.
-
At best, rifamycin SV MMX is still years from the market.
-
The company also possesses a phase III ready candidate in rifamycin SV MMX for traveler's diarrhea.
-
The company also possesses a phase III ready candidate in rifamycin SV MMX for traveler's diarrhea.
-
In the long term, we like the position of the company, especially if Santarus can hold on to Zegerid until either budesonide or rifamycin − or both − gets on the market.
Healthcare Sector and Stocks Analysis from Seeking Alpha Zacks.com 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.